- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05734846
Multifocal Contact Lenses Fitting Methods Comparison
December 18, 2023 updated by: CooperVision, Inc.
Biofinity Multifocal Contact Lenses Fitting Methods Comparison
The purpose of this study was to compare the clinical performance of two fitting approaches for multifocal contact lenses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This was a prospective, cross-over, double-masked (participants and investigator), randomized order of testing study.
It compared two fitting approaches for silicone hydrogel multifocal contact lenses to assess which method achieved greater vision satisfaction and performance.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
London, United Kingdom, SW1E 6AU
- Ocular Technology Group - International
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- At least 40 years old;
- Have read and understood the Participant Information Sheet;
- Have read, signed and dated the Informed Consent;
- Best corrected visual acuity of at least 20/25 in each eye;
- Have normal eyes with the exception of the need for visual correction;
- Current multifocal contact lens wearer;
- Spectacle refraction:
Distance: Sphere: -6.00D to + 4.00D Astigmatism: 0.00D to -0.75D Near Addition: Established Presbyopes: +1.50D & +1.75D
- Be willing and able to adhere to the instructions set in the clinical protocol and maintain the appointment schedule.
Exclusion Criteria:
- Ocular anterior segment infection, inflammation, abnormality, or active disease that would contraindicate contact lens wear;
- Use of systemic or ocular medications for which contact lens wear could be contraindicated as determined by the investigator;
- Monocular participants (only one eye with functional vision) or participants fit with only one lens;
- Any moderate or severe ocular condition observed during the slit-lamp examination at the enrolment visit;
- History of herpetic keratitis, ocular surgery or irregular cornea;
- Known pregnancy or lactation during the study period;
- Enrolment of the investigator or his/her staff, family members of the investigator, family members of the investigator's staff, or individuals living in the households of these individuals.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Control Lenses, then Test Lenses
Participants wore the Control Lenses for 1 week, then crossed over to the Test Lenses for 1 week.
|
Daily wear multifocal lenses for 1 week
Daily wear multifocal lenses for 1 week
|
|
Experimental: Test Lenses, then Control Lens
Participants wore the Test Lenses for 1 week, then crossed over to the Control Lenses for 1 week.
|
Daily wear multifocal lenses for 1 week
Daily wear multifocal lenses for 1 week
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Vision Satisfaction
Time Frame: One week
|
Overall vision satisfaction for each lens was measured on a 0-100 point Visual Analog Scale (VAS), where 0=Extremely Unsatisfied and 100=Extremely Satisfied
|
One week
|
|
Overall Lens Preference
Time Frame: Two weeks
|
Participants selected their preferred lens fitting approach from options - 'Control', 'Test', or 'No Preference'
|
Two weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Overall Binocular Visual Acuity Index
Time Frame: One week
|
Mean binocular visual performance for each lens was measured by timed logMAR charts.
Overall binocular logMAR visual acuity index was calculated by taking the mean of distance and near visual acuities
|
One week
|
|
Number of Contact Lenses
Time Frame: One week
|
This measured the ease of fitting each contact lens.
It counted the number of contact lenses (pair), selected as per the fitting guide, used to determine the final contact lens to dispense.
|
One week
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Michel Guillon, PhD, FCOptom, Ocular Technology Group - International
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 11, 2022
Primary Completion (Actual)
December 1, 2022
Study Completion (Actual)
December 1, 2022
Study Registration Dates
First Submitted
February 9, 2023
First Submitted That Met QC Criteria
February 9, 2023
First Posted (Actual)
February 21, 2023
Study Record Updates
Last Update Posted (Actual)
January 10, 2024
Last Update Submitted That Met QC Criteria
December 18, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CV-22-49
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
Yes
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Presbyopia
-
Ohio State UniversityRecruitingPresbyopia | Presbyopia CorrectionUnited States
-
Bruno Vision Careiuvo BioScience Operations, LLCCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedPresbyopia CorrectionUnited Kingdom
-
VIS, Inc.Active, not recruitingPresbyopia Correction
-
AST Products, Inc.CompletedCataract | Presbyopia CorrectionSpain
-
IROC AGAMO IrelandActive, not recruitingCataract | Presbyopia CorrectionSwitzerland
-
Bausch & Lomb IncorporatedCompletedMyopia and Hyperopia and PresbyopiaUnited States
-
Technolas Perfect Vision GmbHUnknownHyperopic PresbyopiaIreland
-
The Hong Kong Polytechnic UniversityNot yet recruitingPresbyopia | Presbyopia Correction
-
University Eye Hospital SvjetlostCompletedCataract | Visual Acuity | Presbyopia CorrectionCroatia
Clinical Trials on Control Lenses (control fitting approach)
-
CooperVision, Inc.CompletedPresbyopiaUnited States
-
Essilor InternationalActive, not recruitingMyopia | Myopia, ProgressiveSingapore
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
CooperVision, Inc.Completed
-
Essilor InternationalActive, not recruiting
-
Essilor InternationalCompleted
-
Johnson & Johnson Vision Care, Inc.CompletedOcular PhysiologyUnited States
-
Essilor InternationalActive, not recruiting
-
Zhongshan Ophthalmic Center, Sun Yat-sen UniversityGuangzhou Youyan Vision Technology Co., Ltd.Not yet recruiting